first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes glp-1 pregnancy safety news today
Description
After 12 to 18 months, some patients may even be able to stop the GLP-1 drug and use FIM programming for weight maintenance
Many programs now offer hands-on injection training sessions, digital video tutorials, and real-time pharmacist support to improve patient confidence
Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, et al
Zucker I, Zloof Y, Bardugo A, Tsur AM, Lutski M, Cohen Y, et al
